Big Money Sentiment About Utah Medical Products Inc (NASDAQ:UTMD) Increased to 2.24

“Big money” Positions

In 2018 Q2 Utah Medical Products Inc (NASDAQ:UTMD) big money sentiment increased to 2.24, filings reveal. That’s up 1.03, from 2018Q1’s 1.21. 47 institutional investors started new or increased positions, while 21 sold and reduced stakes in Utah Medical Products Inc so the sentiment is positive. These funds own 2.48 million shares, that’s down from 2.48 million shares in 2018Q1. Funds holding Utah Medical Products Inc in top 10 changed to 0 from 0 for the same number . 2 Investors Sold All; 19 Reduced Holdings; 27 increased stakes while 20 institutional investors bought stakes.

Most Utah Medical Products Inc Investors

As of 2018 Q2 Clean Yield Group has 1.41% invested in Utah Medical Products Inc. As of 2018 Q2, 44,150 shares of Utah Medical Products Inc are owned by Thomson Horstmann & Bryant Inc. Morgan Dempsey Capital Management Llc reported 12,386 shares. The Illinois-based fund Ativo Capital Management Llc have invested about 0.37% of the active investment manager’s stock portfolio in Utah Medical Products Inc. The North Carolina-based fund Cardinal Capital Management holds 9,835 shares or 0.33% of their equity exposure.

Utah Medical Products, Inc. develops, makes, and distributes medical devices for the healthcare industry worldwide.The company has $338.62 million market cap. It provides fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system.26.91 is the P/E ratio. The firm also offers umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; and MYELO-NATE, a lumbar sampling kit.

UTMD reached $90.68 during the last trading session after $0.53 change.Currently Utah Medical Products, Inc. is uptrending after 28.26% change in last December 8, 2017. UTMD has 8,475 shares volume. The stock outperformed the S&P500 by 12.64%.

Ancora Advsrs Ltd Limited Liability Company reported 67,387 shs or 0.32% of all its holdings. 60 are owned by Piedmont Investment Advsrs Lc. Geode Mgmt Ltd Limited Liability Company invested 0% of its capital in Utah Medical Products, Inc. (NASDAQ:UTMD). Spark Inv Management Ltd Llc has 5,000 shs. Bancshares Of New York Mellon reported 0% of its capital in Utah Medical Products, Inc. (NASDAQ:UTMD). Signaturefd Lc owns 14 shs or 0% of their US capital. Bridgeway Cap Management Inc accumulated 22,500 shs. 291,584 are held by Price T Rowe Assoc Inc Md. Public Employees Retirement Of Ohio accumulated 4,159 shs or 0% of the stock. 2,794 were accumulated by Manufacturers Life Insur Co The. 2,431 are held by Goldman Sachs Grp Incorporated Inc. 152,244 are owned by Vanguard Grp Inc. Wedge Capital Mgmt L Lp Nc reported 0.02% of its capital in Utah Medical Products, Inc. (NASDAQ:UTMD). Rice Hall James Assocs Lc owns 3,421 shs for 0.01% of their capital. Metropolitan Life Insur Commerce holds 0% of its capital in Utah Medical Products, Inc. (NASDAQ:UTMD) for 1,348 shs.

Utah Medical Products, Inc. registered $1.11 million net activity with 0 insider buys and 3 selling transactions since June 5, 2018. CORNWELL KEVIN L sold $865,132 worth of stock or 8,080 shs.

For more Utah Medical Products, Inc. (NASDAQ:UTMD) news announced recently go to:,,, or The titles are as follows: “Factors of Influence in 2018, Key Indicators and Opportunity within BP plc, Nokia, Xcel Energy, Employers, Utah Medical Products, and Tractor Supply — New Research Emphasizes Economic Growth – Stockhouse” announced on November 01, 2018, “Utah Medical Products, Inc. Increases Quarterly Dividend – Stockhouse” on October 30, 2018, “Benzinga’s Daily Biotech Pulse: Biohaven Sells Right To Drug, Obseva To Sell Shares – Benzinga” with a publish date: June 19, 2018, “In Search Of Dividend Growth: Dividend To Free Cash Flow – Seeking Alpha” and the last “Tracking Small-Cap Super Investor Bares Capital Management – Q2 2014 – Seeking Alpha” with publication date: August 21, 2014.

Utah Medical Products, Inc. (NASDAQ:UTMD) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.